Liraglutide Shows Promise for Liver Health in Non-Alcoholic Steatohepatitis
Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
Abstract
48-week Phase II, Randomised, Double Blinded Placebo Controlled Multicentre Trial on Liraglutide's Safety, Efficacy and Action on Liver Histology and Metabolism in Overweight Patients With NASH +/- Type II Diabetes
NCT ID: NCT01237119
Stat…